These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 20506561)

  • 1. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
    Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
    Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
    Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.
    Consolaro A; Bracciolini G; Ruperto N; Pistorio A; Magni-Manzoni S; Malattia C; Pederzoli S; Davì S; Martini A; Ravelli A;
    Arthritis Rheum; 2012 Jul; 64(7):2366-74. PubMed ID: 22231288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.
    Wallace CA; Giannini EH; Huang B; Itert L; Ruperto N; ; ;
    Arthritis Care Res (Hoboken); 2011 Jul; 63(7):929-36. PubMed ID: 21717596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
    Consolaro A; Ruperto N; Bazso A; Pistorio A; Magni-Manzoni S; Filocamo G; Malattia C; Viola S; Martini A; Ravelli A;
    Arthritis Rheum; 2009 May; 61(5):658-66. PubMed ID: 19405003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
    Ringold S; Wallace CA; Rivara FP
    J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
    Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20.
    Albert DA; Huang G; Dubrow G; Brensinger CM; Berlin JA; Williams HJ
    J Rheumatol; 2004 May; 31(5):856-66. PubMed ID: 15124243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
    Oen K; Duffy CM; Tse SM; Ramsey S; Ellsworth J; Chédeville G; Chetaille AL; Saint-Cyr C; Cabral DA; Spiegel LR; Schneider R; Lang B; Huber AM; Dancey P; Silverman E; Rosenberg AM; Cameron B; Johnson N; Dorval J; Scuccimarri R; Campillo S; Petty RE; Duffy KN; Boire G; Haddad E; Houghton K; Laxer R; Turvey SE; Miettunen P; Gross K; Guzman J; Benseler S; Feldman BM; Espinosa V; Yeung RS; Tucker L
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.
    Aletaha D; Ward MM; Machold KP; Nell VP; Stamm T; Smolen JS
    Arthritis Rheum; 2005 Sep; 52(9):2625-36. PubMed ID: 16142705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
    Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
    Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ; Reiff A; Jones OY; Schneider R; Nocton J; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Whitmore JB; White B; Giannini EH;
    Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis].
    Capela RC; Corrente JE; Magalhães CS
    Rev Bras Reumatol; 2015; 55(1):31-6. PubMed ID: 25440705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.